Markets · Explainer

Lilly Endowment Reports $104.21bn in LLY

Eli Lilly led the share positions in the September filing at $104.21bn.

An archivist climbs a ladder between tall stacks of investment records.
AI-generated illustration: Kunkafa

Kunkafa News · Published · 2 min read

Kareem FaridBy Discuss with the author on X

Key points

  • Lilly Endowment reported 90,066,978 shares or units of LLY on September 30.
  • The leading position accounted for 100.0% of disclosed share and fund-unit value.

Lilly Endowment reported 90,066,978 shares or units of Eli Lilly, worth $104.21bn at the end of September [1].

Lilly Endowment disclosed $104.21bn in LLY at September 30 | Q3 2026 | Kunkafa
0250005000075000100000125000LLY

Source: Form 13F · September 30, 2026 · USD millions

The reported Eli Lilly position fell from 90,376,978 shares or units in June to 90,066,978 in September, a change of 0.3% [1] [2].

Form 13F records quarter-end positions. Changes in reported value reflect market prices as well as changes in the number of shares. The filing does not show trade dates or short stock positions [1].

Lilly Endowment reported 90,066,978 LLY shares or units in September | Q3 2026 | Kunkafa
020000000400000006000000080000000100000000LLY

June 30September 30

Source: Forms 13F · June 30 and September 30, 2026 · shares or fund units

Lilly Endowment · Selected disclosed positions, Q3 2026
SecurityJune 30 unitsSept. 30 unitsSept. USD millions
LLY90,376,97890,066,978104,214.698

Sources: Form 13F · June and September 2026.

Sources: [1] 13F-HR · 2026-10-19 · [2] 13F-HR · 2026-07-23

Kunkafa forecasts

S&P 500 Index

How far it could move, which way, by when, and how confident Kunkafa is.

Check the latest forecasts

More in Markets

From the Blog

All articles